186 related articles for article (PubMed ID: 36434610)
21. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.
Tinay I; Tan M; Gui B; Werner L; Kibel AS; Jia L
Prostate; 2018 Sep; 78(12):927-937. PubMed ID: 29748958
[TBL] [Abstract][Full Text] [Related]
22. Complex Epigenetic Regulation of Chemotherapy Resistance and Biohlogy in Esophageal Squamous Cell Carcinoma via MicroRNAs.
Lindner K; Eichelmann AK; Matuszcak C; Hussey DJ; Haier J; Hummel R
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414899
[TBL] [Abstract][Full Text] [Related]
23. Circulating microRNAs in plasma before and after radical prostatectomy.
McDonald AC; Raman JD; Shen J; Liao J; Pandya B; Vira MA
Urol Oncol; 2019 Nov; 37(11):814.e1-814.e7. PubMed ID: 31421994
[TBL] [Abstract][Full Text] [Related]
24. Identification of miRNA signatures and their therapeutic potentials in prostate cancer.
Karadag A; Ozen A; Ozkurt M; Can C; Bozgeyik I; Kabadere S; Uyar R
Mol Biol Rep; 2021 Jul; 48(7):5531-5539. PubMed ID: 34318435
[TBL] [Abstract][Full Text] [Related]
25. [Expression and clinical significance of microRNA-21-3p and microRNA-551-5p in patients with acute pancreatitis].
Wu K; Wang L; Fu G; Zheng Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):463-467. PubMed ID: 32527354
[TBL] [Abstract][Full Text] [Related]
26. Plasma-based microRNA signatures in early diagnosis of breast cancer.
Li X; Zou W; Wang Y; Liao Z; Li L; Zhai Y; Zhang L; Gu S; Zhao X
Mol Genet Genomic Med; 2020 May; 8(5):e1092. PubMed ID: 32124558
[TBL] [Abstract][Full Text] [Related]
27. [Value of serum miR-155-5p and miR-133a-3p expression for the diagnosis and prognosis evaluation of sepsis].
Lan C; Shi X; Guo N; Pei H; Zhang H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):694-8. PubMed ID: 27434558
[TBL] [Abstract][Full Text] [Related]
28. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis.
Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ
Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822
[TBL] [Abstract][Full Text] [Related]
29. Aberrant expression of five miRNAs in papillary thyroid carcinomas.
Qiao DH; He XM; Deng X; Ji YC; Yang H; Cheng L; Zhou XY
J Clin Lab Anal; 2021 Sep; 35(9):e23907. PubMed ID: 34268792
[TBL] [Abstract][Full Text] [Related]
30. miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer.
Josson S; Gururajan M; Hu P; Shao C; Chu GY; Zhau HE; Liu C; Lao K; Lu CL; Lu YT; Lichterman J; Nandana S; Li Q; Rogatko A; Berel D; Posadas EM; Fazli L; Sareen D; Chung LW
Clin Cancer Res; 2014 Sep; 20(17):4636-46. PubMed ID: 24963047
[TBL] [Abstract][Full Text] [Related]
31. Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy.
Di Cosimo S; Appierto V; Pizzamiglio S; Silvestri M; Baselga J; Piccart M; Huober J; Izquierdo M; de la Pena L; Hilbers FS; de Azambuja E; Untch M; Pusztai L; Pritchard K; Nuciforo P; Vincent-Salomon A; Symmans F; Apolone G; de Braud FG; Iorio MV; Verderio P; Daidone MG
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085669
[TBL] [Abstract][Full Text] [Related]
32. Nano-Vesicles are a Potential Tool to Monitor Therapeutic Efficacy of Carbon Ion Radiotherapy in Prostate Cancer.
Yu Q; Li P; Weng M; Wu S; Zhang Y; Chen X; Zhang Q; Shen G; Ding X; Fu S
J Biomed Nanotechnol; 2018 Jan; 14(1):168-178. PubMed ID: 29463374
[TBL] [Abstract][Full Text] [Related]
33. Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.
Leidinger P; Hart M; Backes C; Rheinheimer S; Keck B; Wullich B; Keller A; Meese E
Tumour Biol; 2016 Aug; 37(8):10177-85. PubMed ID: 26831660
[TBL] [Abstract][Full Text] [Related]
34. [Circulating miR-152 helps early prediction of postoperative biochemical recurrence of prostate cancer].
Chen JF; Liao YF; Ma JB; Mao QF; Jia GC; Dong XJ
Zhonghua Nan Ke Xue; 2017 Jul; 23(7):603-608. PubMed ID: 29723452
[TBL] [Abstract][Full Text] [Related]
35. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
Sahami-Fard MH; Kheirandish S; Sheikhha MH
Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
[TBL] [Abstract][Full Text] [Related]
36. Challenges in Cancer Biomarker Discovery Exemplified by the Identification of Diagnostic MicroRNAs in Prostate Tissues.
Ambrozkiewicz F; Karczmarski J; Kulecka M; Paziewska A; Cybulska M; Szymanski M; Dobruch J; Antoniewicz A; Mikula M; Ostrowski J
Biomed Res Int; 2020; 2020():9086829. PubMed ID: 32462034
[TBL] [Abstract][Full Text] [Related]
37. MiR-139-5p is Increased in the Peripheral Blood of Patients with Prostate Cancer.
Pang C; Liu M; Fang W; Guo J; Zhang Z; Wu P; Zhang Y; Wang J
Cell Physiol Biochem; 2016; 39(3):1111-7. PubMed ID: 27562849
[TBL] [Abstract][Full Text] [Related]
38. Relationship of the Levels of microRNA Gene Methylation with the Level of Their Expression and Pathomorphological Characteristics of Breast Cancer.
Filippova EA; Pronina IV; Lukina SS; Kazubskaya TP; Braga EA; Burdennyi AM; Loginov VI
Bull Exp Biol Med; 2021 Oct; 171(6):764-769. PubMed ID: 34705180
[TBL] [Abstract][Full Text] [Related]
39. Combined Detection of Serum MiR-221-3p and MiR-122-5p Expression in Diagnosis and Prognosis of Gastric Cancer.
Zhang Y; Huang H; Zhang Y; Liao N
J Gastric Cancer; 2019 Sep; 19(3):315-328. PubMed ID: 31598374
[TBL] [Abstract][Full Text] [Related]
40. A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer.
Daniel R; Wu Q; Williams V; Clark G; Guruli G; Zehner Z
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]